Explore 3 Stock Ideas & Industry Insights Download Free Report

Announcements

Saia VP Benton Withholds 129 Shares in Tax Event

Kelly W. Benton, VP and Chief Accounting Officer of Saia Inc, filed a Form 4 on November 4, 2026, disclosing a share withholding transaction on November 2, 2026, related to the vesting of restricted shares originally awarded in November 2022.

Shwetambri Chauhan | 04 November 2026

Das and Patel: 266,590 SPAC Units at $10 on Oct 28

An amended beneficial ownership statement covering a transaction dated October 28, 2026 was filed on November 4, 2026, by Soumen Das, MiteshKumar Patel, SPACCatalyst LLC, and SPACCircle Sponsor LLC, each identified as reporting persons with respect to SPACCircle Acquisition Corp. (NASDAQ:SCQCU).

Aditi Sarkar | 04 November 2026

SPACCircle Sponsor Forfeits 750,000 Class B Shares After IPO

A Statement of Changes in Beneficial Ownership was filed on November 4, 2026, disclosing that SPACCircle Sponsor LLC surrendered 750,000 Class B ordinary shares of SPACCircle Acquisition Corp. to the issuer for no consideration, following the underwriters' forfeiture of the over-allotment option in connection …

Aakashdeep | 04 November 2026

Fowler Todd C. Files Initial Ownership Statement for Saia Inc

Director Todd C. Fowler filed a Form 3 Initial Statement of Beneficial Ownership with the SEC on November 4, 2026, disclosing his initial beneficial ownership position in Saia Inc following an event date of October 29, 2026.

Vinay Lochav | 04 November 2026

Fred Hassan Gets 156,658 RSU Grant from Recursion Pharma

Director Fred Hassan filed a Form 4 with the SEC on November 4, 2026, disclosing the acquisition of 156,658 restricted stock units in Recursion Pharmaceuticals, Inc. on November 2, 2026.

Manish Choudhary | 04 November 2026

Borgeson Sells 40,000 Recursion Pharma Shares at $3.88

Director Blake Borgeson of Recursion Pharmaceuticals, Inc. filed a Form 4 on November 4, 2026, disclosing the sale of 40,000 shares of Class A Common Stock on November 3, 2026, under a pre-established Rule 10b5-1 trading plan.

Aditi Sarkar | 04 November 2026

Fred Hassan Joins Recursion Pharmaceuticals Board

Fred Hassan filed an initial statement of beneficial ownership with the SEC on November 4, 2026, disclosing his status as a newly appointed director of Recursion Pharmaceuticals, Inc. as of October 31, 2026.

Vinay Lochav | 04 November 2026

Kodiak AI Chief People Officer Boyd Files Form 3

Lorie Ann Boyd, Chief People Officer of Kodiak AI, Inc., filed an initial statement of beneficial ownership (Form 3) on November 4, 2026, with an event date of November 2, 2026.

Manish Choudhary | 04 November 2026

Soumen Das Files Form 3/A for SPACCircle Acquisition Corp.

An amended initial statement of beneficial ownership (Form 3/A) was filed on November 4, 2026, by Soumen Das, Miteshkumar Patel, SPACCircle Sponsor LLC, and SPACCatalyst LLC, each reporting their relationship to SPACCircle Acquisition Corp. as of the event date of October 26, 2026.

Anjali Anand | 04 November 2026

Honroth Receives 101,193 Shares in AngioDynamics CEO Grant

AngioDynamics President and CEO Eric Honroth filed a Form 4 on November 4, 2026, disclosing the acquisition of restricted stock units and performance rights on November 2, 2026, resulting in beneficial ownership of 101,193 shares of common stock.

Aakashdeep | 04 November 2026
Support

Hi! How can we help you today?

Loading…